Page last updated: 2024-10-24

entry into host cell by a symbiont-containing vacuole

Definition

Target type: biologicalprocess

The invasion by a symbiont of a cell of a host organism, forming a vacuole in which the symbiont resides. The vacuole membrane is formed from lipids and proteins derived from both host and symbiont. Begins when the symbiont attaches on to the host cell membrane which invaginates and deepens as the symbiont enters, and ends when the host cell membrane closes behind the newly-formed vacuole. [GOC:jl, PMID:18665841, PMID:8690024, PMID:9580555]

The entry of a symbiont-containing vacuole into a host cell is a complex and tightly regulated process that varies depending on the specific symbiosis. However, some general steps are common:

1. **Attachment:** The symbiont-containing vacuole first attaches to the host cell membrane. This attachment can be mediated by specific receptors on the host cell surface and ligands on the vacuole.

2. **Internalization:** Once attached, the vacuole is internalized into the host cell through a process called endocytosis. This process involves the invagination of the host cell membrane, surrounding the vacuole, and eventually pinching off to form a vesicle containing the vacuole.

3. **Trafficking:** The newly formed vesicle containing the symbiont-containing vacuole is transported through the host cell cytoplasm to its final destination. This trafficking often involves specific motor proteins that move along cytoskeletal filaments, allowing the vesicle to travel to the appropriate location.

4. **Fusion:** Once at its destination, the vacuole membrane can fuse with the host cell membrane, releasing the symbiont into the host cell cytoplasm. This fusion can be regulated by specific fusion proteins on both the vacuole and host cell membranes.

5. **Establishment of the Symbiotic Relationship:** Once inside the host cell, the symbiont can establish a symbiotic relationship with the host cell. This can involve various interactions, such as the exchange of nutrients and signaling molecules.

It is important to note that the specific mechanisms of entry, trafficking, and fusion can vary significantly between different symbioses. For instance, some symbionts may enter the host cell through phagocytosis, while others may enter through a process called microinjection. Additionally, the fate of the symbiont-containing vacuole can vary, with some symbionts remaining within the vacuole, while others escape into the host cell cytoplasm.'
"

Proteins (1)

ProteinDefinitionTaxonomy
Integrin alpha-V An integrin alpha-V that is encoded in the genome of human. [PRO:DNx, UniProtKB:P06756]Homo sapiens (human)

Compounds (22)

CompoundDefinitionClassesRoles
1-(3-chlorophenyl)biguanide1-(3-chlorophenyl)biguanide: RN given refers to parent cp; a 5-HT3 receptor agonistbiguanides;
monochlorobenzenes
phenyl biguanidephenyl biguanide : A member of the class of biguanides that is biguanide in which one of the terminal nitrogen atoms is substituted by a phenyl group.

phenyl biguanide: RN given refers to parent cpd
guanidinescentral nervous system drug
4-chlorophenylbiguanide
paclitaxelTaxus: Genus of coniferous yew trees or shrubs, several species of which have medicinal uses. Notable is the Pacific yew, Taxus brevifolia, which is used to make the anti-neoplastic drug taxol (PACLITAXEL).taxane diterpenoid;
tetracyclic diterpenoid
antineoplastic agent;
human metabolite;
metabolite;
microtubule-stabilising agent
tirofibantirofiban : A member of the class of piperidines that is L-tyrosine in which a hydrogen attached to the amino group is replaced by a butylsulfonyl group and in which the hydrogen attached to the phenolic hydroxy group is replaced by a 4-(piperidin-4-yl)butyl group.

Tirofiban: Tyrosine analog and PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX antagonist that inhibits PLATELET AGGREGATION and is used in the treatment of ACUTE CORONARY SYNDROME.
L-tyrosine derivative;
piperidines;
sulfonamide
anticoagulant;
fibrin modulating drug;
platelet glycoprotein-IIb/IIIa receptor antagonist
25-hydroxycholesterol25-hydroxy steroid;
oxysterol
human metabolite
tetraiodothyroacetic acid3,3',5,5'-tetraiodothyroacetic acid : A monocarboxylic acid that is thyroacetic acid carrying four iodo substituents at positions 3, 3', 5 and 5'.

tetraiodothyroacetic acid: RN given refers to parent cpd; structure
2-halophenol;
aromatic ether;
iodophenol;
monocarboxylic acid
apoptosis inducer;
human metabolite;
thyroid hormone
arginyl-glycyl-aspartic acidarginyl-glycyl-aspartic acid: amino acid sequence of basic unit of widespread cellular recognition systemoligopeptide
glycyl-arginyl-glycyl-aspartyl-serineglycyl-arginyl-glycyl-aspartyl-serine: synthetic peptide from fibronectins; inhibits experimental metastasis of murine melanoma cells
glycyl- arginyl-glycyl-aspartyl-seryl-prolyl-lysine
d-arg-gly-asp-trparginyl-glycyl-aspartyl-tryptophan: a synthetic RGD-containing peptide
l 738167L 738167: structure in first source
sk&f 107260SK&F 107260: structure given in first source
cilengitideCilengitide: an alphaVbeta3 integrin antagonist that paralyzes cancer cellsoligopeptide
l 734217L 734217: fibrinogen receptor antagonist; structure given in first source
elarofibanelarofiban: a GPIIb and GPIIIa receptor antagonist; structure in first source
eptifibatidehomodetic cyclic peptide;
macrocycle;
organic disulfide
anticoagulant;
platelet aggregation inhibitor
arginyl-glycyl-aspartyl-phenylalanine
sb 223245
cyclic(arg-gly-asp-d-phe-val)
mk-0429
sb 273005